FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Doris Hofer

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

COS Cells

Co-author Network

Publications

TOP 3
Z S Gucev; Doris Hofer; I Kremensky; Nada Pop-Jordanova; I Sinigerska; Velibor Tasic; R Tincheva; D Danilovski; Eduard Paschke
Hunter syndrome (Muccopolysaccharridosis Type II) in Macedonia and Bulgaria.
Doris Hofer; K Paul; K Fantur; M Beck; A Roubergue; A Vellodi; B J Poorthuis; Helen Michelakakis; Barbara Plecko; Eduard Paschke
Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations.
Katrin Fantur; Doris Hofer; Georg Schitter; Andreas J Steiner; Bettina M Pabst; Tanja M Wrodnigg; Arnold E Stütz; Eduard Paschke
DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Doris Hofer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Z S Gucev; Doris Hofer; I Kremensky; Nada Pop-Jordanova; I Sinigerska; Velibor Tasic; R Tincheva; D Danilovski; Eduard Paschke
Hunter syndrome (Muccopolysaccharridosis Type II) in Macedonia and Bulgaria.
Prilozi / Makedonska akademija na naukite i umetnostite, Oddelenie za biološki i medicinski nauki = Contributions / Macedonian Academy of Sciences and Arts, Section of Biological and Medical Sciences 2011;32(2):187-98.
2010: Doris Hofer; K Paul; K Fantur; M Beck; A Roubergue; A Vellodi; B J Poorthuis; Helen Michelakakis; Barbara Plecko; Eduard Paschke
Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations.
Clinical genetics 2010;78(3):236-46.
2010: Katrin Fantur; Doris Hofer; Georg Schitter; Andreas J Steiner; Bettina M Pabst; Tanja M Wrodnigg; Arnold E Stütz; Eduard Paschke
DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.
Molecular genetics and metabolism 2010;100(3):262-8.
2009: Doris Hofer; Karl Paul; Katrin Fantur; Michael Beck; Friederike Bürger; Catherine Caillaud; Ksenija Fumic; Jana Ledvinova; Agnieszka Lugowska; Helen Michelakakis; Briguita Radeva; Uma Ramaswami; Barbara Plecko; Eduard Paschke
GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.
Human mutation 2009;30(8):1214-21.
2007: Christian Rosker; Birgit Lohberger; Doris Hofer; Bibiane Steinecker; Stefan Quasthoff; Wolfgang Schreibmayer
The TTX metabolite 4,9-anhydro-TTX is a highly specific blocker of the Na(v1.6) voltage-dependent sodium channel.
American journal of physiology. Cell physiology 2007;293(2):C783-9.
2006: Doris Hofer; Birgit Lohberger; Bibiane Steinecker; Kurt Schmidt; Stefan Quasthoff; Wolfgang Schreibmayer
A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.
European journal of pharmacology 2006;538(1-3):5-14.
2003: Stefan Quasthoff; Christine Pojer; Alexander Mori; Doris Hofer; Peter M Liebmann; Bernd C Kieseier; Wolfgang Schreibmayer
No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve.
Neuroscience letters 2003;352(2):93-6.
2000: Doris Hofer; Marcela Raíces; Konrad Schauenstein; S Porta; W Korsatko; Karl Hagmüller; Angel A Zaninovich
The in vivo effects of beta-3-receptor agonist CGP-12177 on thyroxine deiodination in cold-exposed, sympathectomized rat brown fat.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(2):273-7.
1998: I Rinner; P Felsner; Peter M Liebmann; Doris Hofer; Albert Wölfler; A Globerson; Konrad Schauenstein
Adrenergic/cholinergic immunomodulation in the rat model--in vivo veritas?
Developmental immunology 1998;6(3-4):245-52.
1997: Peter M Liebmann; Albert Wölfler; P Felsner; Doris Hofer; Konrad Schauenstein
Melatonin and the immune system.
International archives of allergy and immunology 1997;112(3):203-11.
1996: I Rinner; P Felsner; Doris Hofer; Amiela Globerson; Konrad Schauenstein
Characterization of the spontaneous apoptosis of rat thymocytes in vitro.
International archives of allergy and immunology 1996;111(3):230-7.
1996: Peter M Liebmann; Doris Hofer; P Felsner; Albert Wölfler; Konrad Schauenstein
Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin release.
Journal of neuroimmunology 1996;67(2):137-42.
1995: Peter M Liebmann; Doris Hofer; A Absenger; P Zimmermann; U Weiss; S Porta; Konrad Schauenstein
Computer-controlled flushing for long-term cannulation in freely moving rats.
Journal of pharmacological and toxicological methods 1995;34(4):211-4.
1995: P Felsner; Doris Hofer; I Rinner; S Porta; W Korsatko; Konrad Schauenstein
Adrenergic suppression of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha 2-receptors.
Journal of neuroimmunology 1995;57(1-2):27-34.
1992: P Felsner; Doris Hofer; I Rinner; Harald Mangge; M Gruber; W Korsatko; Konrad Schauenstein
Continuous in vivo treatment with catecholamines suppresses in vitro reactivity of rat peripheral blood T-lymphocytes via alpha-mediated mechanisms.
Journal of neuroimmunology 1992;37(1-2):47-57.